Cervical cancer screening by enhanced cytology: application of novel markers by Cheung, ANY et al.
Title Cervical cancer screening by enhanced cytology: application ofnovel markers
Author(s) Cheung, ANY; Guan, X; Ngan, HYS
Citation Hong Kong Medical Journal, 2014, v. 20 n. 6, Suppl. 6, p. 39-43
Issued Date 2014
URL http://hdl.handle.net/10722/216799
Rights Hong Kong Medical Journal. Copyright © Hong Kong Academyof Medicine Press.
39Hong Kong Med J  ⎥  Volume 20 Number 6 (Supplement 6)  ⎥  December 2014  ⎥  www.hkmj.org
K e y  M e s s a g e s 
1. p634A4, TAp73, and DJ-1 immunocytochemistry 
as well as in situ hybridisation for the OSMR1, 
PAPD7/POLS, PRAKK1, and TRIO genes helped 
to identify cervical carcinoma and high-grade 
precursor cells. 
2. p634A4 immunoreactivity is a potential 
marker for triage of atypical squamous cells of 
undetermined significance.
3. TAp73 immunoreactivity is a potential marker 
for triage of low-grade squamous intraepithelial 
Cervical cancer screening by enhanced cytology: 
application of novel markers
Introduction
Cervical cytological examination is the most widely 
applied screening method for cervical cancer and its 
precursors. Liquid-based cytology produces good-
quality smears1 and enables the use of ancillary 
laboratory techniques to distinguish neoplastic from 
benign cells.1
 Immunohistochemical and molecular 
markers have been tested to identify dysplastic 
cells in cervical smears. When testing for human 
papillomavirus (HPV) or chromosome aneusomy, 
MIB1 (Ki67) and p16 immunocytochemistry helps 
to highlight dysplastic or cancer cells.2 Such markers 
may be useful for triage of patients with borderline 
smears of atypical squamous cells of undetermined 
significance (ASCUS), which is the most common 
abnormal cytological finding and is associated with 
a significantly higher risk of developing cervical 
cancer and its high-grade precursors.
 In this study, immunocytochemical 
markers (p63, p73, Eif-5A2, and DJ-1 genes) 
were tested in cervical cancer screening using 
immunocytochemistry and chromogenic in situ 
hybridisation. Differential expression of these genes 
in cervical cytology is useful in diagnosing cervical 
cancer.
 p63 and p73 genes are members of the p53 
family and play important roles in carcinogenesis. 
Different isoforms of p63 and p73 can enhance 
or suppress neoplastic cell growth. Differential 
expression of p63 and p73 isoforms was reported 
in normal and neoplastic cervical epithelium. p73 
expression is associated with radiosensitivity of 
cervical cancer.3 In a study of frequently amplified 
regions at 3q26.2, Eif-5A2 was found to be important 
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in ovarian carcinogenesis.4 Similar regions at 
chromosome 3q have also been identified in cervical 
cancer. Eif-5A2 is a potential marker for cervical 
cancer. DJ-1 has been identified as a suppressor 
of PTEN, which is a tumour suppressor gene. 
DJ-1 overexpression has been noted in human 
malignancies compared with healthy tissue. 
 Novel genes can be identified in specific 
chromosome regions by array comparative genomic 
hybridisation. In our previous studies on cervical 
cancer samples and cell lines, the frequently 
amplified regions were 1q, 3p, 3q, and 5p.5 Besides 
Eif-5A2, eight gene loci can be identified and the 
amplification status can be detected by chromogenic 
in situ hybridisation. This study aimed to assess the 
application value of adjunct markers in liquid-based 
cervical cytology for detection of carcinoma cells 
and precursors.
Methods
This study was conducted from March 2007 to 
February 2009. Residues of liquid-based ThinPrep 
Pap Test (Hologic, Bedford, MA, US) cervical 
cytology samples of high-grade squamous 
intraepithelial lesions (HSIL) [n=80], low-grade 
SIL (LSIL) [n=100], ASCUS (n=200), invasive 
cervical carcinoma (n=40), and healthy tissue (n=60) 
findings were retrieved from the Cervical Cytology 
Laboratory, Queen Mary Hospital, University of 
Hong Kong for immunocytochemistry and in situ 
hybridisation.1 Cervical cancer cell lines HeLa, SiHa, 
ME180, and C4-1P3 as well as the ovarian cancer cell 
line UACC1895 were used as controls. Expression 
of p63, p73, Eif-5A2, and DJ-1 genes was studied 
immunocytochemically. 
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 To identify the eight target genes for 
chromogenic in situ hybridisation experiments, 
quantitative real-time polymerase chain reaction 
(PCR) using DNA extracted from healthy tissue 
(n=6), HSIL (n=14), and squamous cell carcinoma 
(SCC) [n=12] cytology samples was performed. 
The DNA probes for Eif-5A2 and the eight other 
selected gene loci on 1q, 3p, 3q, and 5p were labelled 
with biotin, and chromogenic in situ hybridisation 
was performed. The subsequent cytology and 
colposcopic histology findings of the cases were 
traced. The HPV molecular test results, if available, 
were also retrieved for correlation.
 Apart from Eif-5A2, potential genes located 
on 1q, 3p, 3q, and 5p for in situ hybridisation 
were explored through literature review followed 
by screening by quantitative PCR (qPCR).5 The 
genomic sequences of potential target genes were 
retrieved from the UCSC Genome Browser (http://
genome.ucsc.edu/cgi-bin/hgGateway). Primers were 
designed using NCBI/Primer-BLAST (http://www.
ncbi.nlm.nih.gov/tools/primer-blast/). qPCR was 
performed on DNA extracted from pilot samples 
with ABI Prism 7700 Sequence Detection System 
(Applied Biosystems, Foster City, CA, USA). 
 After screening by real time PCR, eight 
genes with demonstrable amplification status 
in the cervical cancer samples were selected for 
chromogenic in situ hybridisation. These included 
MUC1 (on 1q), MST1R (on 3p), DVL3 and FGF12 
(on 3q), and OSMR1, PAPD7/POLS, PRAKK1, 
and TRIO (on 5p). The probes were designed and 
manufactured using the assay services of Empire 
Genomics (New York, NY, USA). Bacterial artificial 
chromosome clones for these eight genes and non-
repetitive sequences of MAN2A1 on chromosome 5, 
which acted as control for the genes on chromosome 
5, were prepared. The location and clone percent 
coverage are listed in the Table. Plasmids containing 
pericentromeric regions for chromosomes 1 and 
3 were used as controls for the genes on these 
chromosomes. After culture, the plasmid DNA 
was isolated by the alkaline lysis method followed 
by biotin labelling using BioPrime DNA Labeling 
System (Invitrogen; Life Technologies, Paisley, UK). 
 Chromogenic in situ hybridisation was 
performed following established protocols.2 
The slides were first incubated with 0.1% Triton 
X-100 and proteinase K. The labelled probes 
were added to the hybridisation mix, followed by 
overnight hybridisation. Immunocytochemistry 
was performed to visualise in situ hybridisation 
signals by peroxidase activity. Known positive and 
negative control slides were included in each batch 
of experiments. The morphology of the nuclei was 
taken into consideration during evaluation of in situ 
hybridisation signals. 
  Regarding immunocytochemistry, mouse anti-
human p63 (Clone 4A4; Dako, Glostrup, Denmark), 
mouse anti-human TAp73 (Zymed Laboratories, 
San Francisco, CA, USA), DJ-1 (a gift from Prof Tak 
W Mak, Ontario Cancer Institute, Toronto, Canada), 
and mouse monoclonal antibody to EIF-5A2 
(ab57421; Abcam, Cambridge, MA, USA) were 
applied to the ThinPrep thin-layer cytology slides. 
Immunocytochemical studies were performed using 
the EnVision+ Dual Link System (Dako, Carpinteria, 
CA, USA). A light haematoxylin counterstain was 
used. Appropriate negative and positive controls 
were included. A modified Wentzensen scoring 
system incorporating morphologic criteria for the 
assessment of the immunoreactivity of the cells was 
used. 
 Chi-squared test (2-tailed) was used to compare 
the immunocytochemical and in situ hybridisation 
signals among the healthy tissue, ASCUS, LSIL, 
HSIL, and cervical carcinoma groups. A P value of 
<0.05 was considered statistically significant. 
Results
Immunocytochemistry
p634A4 protein expression was found mainly at 
the nuclei, although weak cytoplasmic expression 
TABLE.  Location and clone percent coverage of in situ hybridisation probes
Gene Chromosome Clone Clone percent coverage (%) Chromosome start and stop location
DVL3 3q RP11-814O14 100 185355977-185374008
Eif-5A2 3q RP11-115J24 93.5 172090216-172251852
FGF12 3q RP11-767C10 73.2 193362761-193557602
MST1R 3p RP11-915H6 100 49782629-49932767
MUC1 1q RP11-263K19 100 153361602-153541655
OSMR 5p RP11-113D9 100 38808720-38981485
PAPD7 5p RP11-681G24 100 6761120-6934896
PRKAA1 5p RP11-357L11 100 40786785-40949438
TRIO 5p RP11-481M12 53.7 14308043-14504474
MAN2A1 5q RP11-259F13 95.3 109057383-109227354
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was detected focally (Fig 1a). Significantly higher 
p634A4 expression was found in HSIL or carcinoma 
when compared with ASCUS and LSIL (P<0.05). 
Among ASCUS, p634A4 expression in cases that 
subsequently progressed to LSIL (P<0.05) or HSIL 
(P<0.05) was significantly higher than those that did 
not. For ASCUS positive for high-risk HPV detected 
by hybrid capture II, cases with a high p634A4 index 
were more likely to have subsequent HSIL detected 
(P<0.05). 
 TAp73 protein expression was found mainly 
at the nuclei, although weak cytoplasmic expression 
was detected focally (Fig 1b). Significantly higher 
TAp73 expression was found in HSIL or carcinoma 
when compared with ASCUS and LSIL (P<0.05). 
Among LSIL, significantly higher TAp73 (P<0.05) 
was found in cases that subsequently progressed to 
HSIL. TAp73 correlated with the p634A4 indices 
(P<0.0001).
 DJ-1 protein expression was found at both the 
cytoplasm and the nucleus of SCC cells, whereas 
the healthy squamous cells were negative for DJ-1 
protein. There was a significant difference in DJ-1 
expression among the different diagnostic categories 
of healthy tissue, ASCUS, LSIL, HSIL, and SCC 
(P<0.05). Significantly higher DJ-1 expression was 
found in HSIL and SCC than in ASCUS and LSIL 
(P<0.05).
 No significant Eif-5A2 protein expression 
was detected in SCC, HSIL, LSIL, and ASCUS 
cells. Only a few HSIL, LSIL, and ASCUS cells in 
a small number of samples showed weak Eif-5A2 
expression. In contrast, strong expression of Eif-5A2 
was demonstrated in the control ovarian cancer cell 
line UACC1895.
Chromogenic in situ hybridisation
There were two to 14 copy signals for DVL3 and three 
to 10 copy signals for FGF12, both on chromosome 
3q, and two to 10 copy signals for MST1R on 
chromosome 3p detected in SCC and HSIL samples. 
Aneusomy of chromosome 3 was suggested by 
the multiple (2-8) copy signals for chromosome 3 
centromere. There was no significant increase in the 
ratio of DVL3, FGF12, and MST1R to centromere 3 
in SCC and HSIL samples (P>0.05), indicating no 
significant amplification of these genes in SCC and 
HSIL.
 No increase in in situ hybridisation signals 
for Eif-5A2 (on chromosome 3q) could be detected 
in carcinoma, HSIL, LSIL, and ASCUS cells. In 
contrast, multiple copy signals were found in the 
control ovarian cancer cell line UACC1895. 
 There were two to 10 copy signals for MUC1 
on chromosome 1q detected in SCC and HSIL 
samples. Aneusomy of chromosome 1 was suggested 
by the multiple (2-7) copy signals for chromosome 
1 centromere. There was no significant increase in 
the MUC1 to centromere 1 ratio in SCC and HSIL 
samples (P>0.05) suggesting absence of amplification 
of the MUC1 gene in these lesions.
 Overall, three to eight copy signals for OSMR 
and PRAD7/POLS each, and two to 10 copy signals 
for PRKAA1 and RIO each on chromosome 5p were 
detected in SCC and HSIL samples, whereas two 
copy signals for the non-replicating MAN2A-1 gene 
on chromosome 5 were detected (Fig 2). There was 
a significant increase in the ratio of OSMR, PRAD7/
POLS, PRKAA1, and TRIO to centromere 5 in SCC 
and HSIL samples (P<0.05) suggesting amplification 
of these genes in SCC and HSIL.
Specificity of predicting cervical lesions
When compared with the high-risk HPV test, p634A4 
immunocytochemistry increased the specificity and 
positive predictive value, although the sensitivity 
and negative predictive value were reduced.
Discussion 
The selected gene loci have been found to occupy 
essential niches in cervical carcinogenesis. Among 
the six major hallmarks of cancer, these genes have 
been found to play a role in evading apoptosis (p63, 
FIG 1.  Overexpression of (a) p634A4 and (b) TAp73 in 
squamous cell carcinoma cells
(a)
(b)
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p73, DJ-1, TRIO, Eif-5A2), self-sufficiency in growth 
signals (DVL3, FGF12, MST1R, OSMR, PAPD7/
POLS), insensitivity to anti-growth signals (p63, 
p73, DJ-1, MUC1, PAPD7/POLS), and sustained 
angiogenesis (PRKAA1). 
 In this study, the potential of p63 and p73 
in highlighting SCC and HSIL, and in triaging 
ASCUS and LSIL (even among HPV-positive cases 
for ASCUS) was demonstrated. Nonetheless, the 
application of p63 and p73 immunocytochemistry, 
particularly p63, may have limitations for detecting 
glandular lesions in cervical cytology.
 High expression of DJ-1 rendered cells resistant 
to apoptosis and overexpression of DJ-1 has been 
reported in various human cancers. In this study, 
high DJ-1 expression was also found in SCC and 
HSIL, suggesting its role as cancer marker. However, 
DJ-1 cannot be used to triage ASCUS or LSIL cases 
for subsequent development of HSIL or SCC.
 Overexpression of Eif-5A2 has been reported in 
several cancers, suggesting it is a potential oncogene. 
Almost all of the carcinomas with overexpression of 
Eif-5A2 were adenocarcinomas. In our pilot study, 
Eif-5A2 was found to be overexpressed in cervical 
adenocarcinoma, but to a much lesser extent in 
SCC. Overexpression or amplification of Eif-5A2 
was not detected in the cervical cytology samples. 
Tissue-specific functions of the Eif-5A2 isoform 
may exist. Different gene expression profiles for 
adenocarcinoma and SCC have been demonstrated.
 Dishevelled (Dvl) family gene products, 
cytoplasmic mediators of the Wnt/beta-catenin 
signalling pathway, are important in embryological 
development. DVL3 was found to be overexpressed 
in cancers relative to metastatic ability. Nevertheless, 
amplification of DVL3 was not detected in cervical 
cancers in this study.
 In oesophageal SCC, FGF12 was found to be 
associated with cellular migration, proliferation, and 
inhibition of apoptosis. Expression of FGF12, related 
to the MAPK signalling pathway, was validated 
by tissue microarray. Amplification of FGF12 has 
not been reported in cervical cancers and was not 
detected in the cytology samples of cervical cancers 
in our study.
 MST1R, which maps at 3p21.3, encodes a 
tyrosine kinase receptor closely related to the MET 
gene, whose mutations and dysregulated expression 
are associated with cancers of the lung and breast in 
association with metastasis and death. MST1R forms 
a complex with the epidermal growth factor receptor 
and acts as a transcriptional regulator in response to 
stress signals imposed on cancer cells. Nevertheless, 
amplification of MST1R was not detected in cervical 
cancers in this study.
 Frequent amplification of MUC1 at 1q has been 
reported in cancers of the breast, ovary, and thyroid 
in association with aggressive clinical behaviour and 
resistance to chemotherapy. High MUC1 expression 
has been reported in cervical cancers, predominantly 
in adenocarcinoma. In this study, amplification of 
MUC1 was not demonstrated in cytology samples of 
SCC and HSIL. 
 Amplification of OSMR at 5p has been 
reported in SCC of the cervix, adversely influencing 
overall patient survival independently of tumour 
stage. OSMR could activate downstream signalling 
pathways, including STAT3 and MAPK, and induce 
transcription of the angiogenic factor vascular 
endothelial growth factor. Our study confirmed the 
amplification of OSMR in SCC and HSIL cytology 
samples.
 The PAPD7/Pols gene, which encodes a DNA 
polymerase, is necessary for chromosome segregation 
and establishing sister chromatid cohesion after S-
phase. These processes are important for regulation 
of the cell cycle. Amplification of PAPD7/Pols has 
been demonstrated in cervical cancers as well as 
soft-tissue sarcomas. Amplification of PAPD7/Pols 
was also detected in SCC and HSIL cytology samples 
in this study.
 The PRKAA1 gene codes for the catalytic alpha 
1 subunit of the AMP-activated protein kinase, 
FIG 2.  Amplification of TRIO is reflected by increases in in 
situ hybridisation signals for (a) MAN2A1 and (b) TRIO
(a)
(b)
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which is an important cellular metabolic stress 
regulator. Amplification and overexpression of 
PRKAA1 has been reported in our earlier studies of 
cervical cancers, supporting its potential in cervical 
carcinogenesis. The amplification was confirmed by 
chromogenic in situ hybridisation in this study. 
 Amplification of TRIO at 5p15.2 has been 
demonstrated in oral, oesophageal, and urinary 
bladder cancers, in association with aggressive 
tumour growth and proliferation and reduced 
apoptosis. TRIO amplification is also found in 
primary cervical cancers, adversely influencing 
patients’ survival. Amplification of TRIO was 
confirmed in this study.
Study limitations
This study was limited to evaluation of gene 
expression and amplification in SCC and squamous 
lesions in cervical cytology. Adenocarcinoma and its 
precursors were not studied. 
Conclusion
In liquid-based cytology samples, TAp73, p634A4, 
and DJ-1 immunocytochemistry and detection of 
amplified gene copies of OSMR1, PAPD7/POLS, 
PRAKK1, and TRIO by in situ hybridisation together 
with morphological assessment could distinguish 
cervical cancer from its high-grade precursors. In 
addition, p634A4 and TAp73 immunoreactivity 
correlated with subsequent detection of HSIL or 
SCC in patients with ASCUS and LSIL, respectively, 
with enhanced specificity. p634A4 and TAp73 
immunoreactivity may thus be potential markers for 
triage of borderline and low-grade cervical smears. 
Such adjunct markers can identify at-risk patients 
and reduce unnecessary referral for colposcopy.
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